57468-16-3

57468-16-3 structure
57468-16-3 structure
  • Name: Substance P(1-4)
  • Chemical Name: 1-[6-amino-2-[[1-[2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid
  • CAS Number: 57468-16-3
  • Molecular Formula: C22H40N8O5
  • Molecular Weight: 496.60400
  • Catalog: Research Areas Cancer
  • Create Date: 2018-12-22 20:56:59
  • Modify Date: 2025-08-22 20:11:12
  • Substance P(1-4) is a potent neurokinin receptors (NK-R) antagonist. Substance P(1-4) has regulation of normal hematopoiesis and inhibits endogenous erythroid colony (EEC) formation[1].

Name 1-[6-amino-2-[[1-[2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid
Synonyms Arg-Pro-Lys-Pro
1-(6-amino-2-{[1-(2-amino-5-carbamimidamidopentanoyl)pyrrolidin-2-yl]formamido}hexanoyl)pyrrolidine-2-carboxylic acid
substance P(1-4)
SUBSTANCE P,Fragment 1-4
Description Substance P(1-4) is a potent neurokinin receptors (NK-R) antagonist. Substance P(1-4) has regulation of normal hematopoiesis and inhibits endogenous erythroid colony (EEC) formation[1].
Related Catalog
In Vitro Substance P(1-4) (0.1 nM-1 μM) inhibits endogenous erythroid colony (EEC) formation in PV bone marrow cultures[1]. Substance P(1-4) (0.1 nM-1 μM; CD36+/GpA- cells) decreases of erythroid colony numbers of 47% and inhibits proliferation of PV CD36+/GpA- cells of 30 %[1]. Cell Viability Assay[1] Cell Line: PV CD36+/GpA- cells Concentration: 0.1 nM-1 μM Incubation Time: 2 days Result: Inhibited proliferation of PV CD36+/GpA- cells of 30 %. Apoptosis Analysis[1] Cell Line: PV CD36+/GpA- cells Concentration: 10 nM Incubation Time: 2 days Result: Increased the percentage of cell death of 27.3%.
Molecular Formula C22H40N8O5
Molecular Weight 496.60400
Exact Mass 496.31200
PSA 220.96000
LogP 1.11560
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.